[ad_1]
The British pharmaceutical giant beat expectations but saw its share price drop on investors’ concerns about lawsuits surrounding its Zantac heartburn medicine
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...